Coya Therapeutics, Inc. Stock Analysis & AI Score
Coya Therapeutics, Inc. (COYA) has an ST Score of 64.5 (B), driven by its Profitability (A+) and held back by its Growth (F). Analysts rate it Buy with a $12.00 price target (+131.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Coya Therapeutics, Inc. (COYA) has an ST Score of 64.5 (B), driven by its Profitability (A+) and held back by its Growth (F). Analysts rate it Buy with a $12.00 price target (+131.7% upside).
- Strongest
- ProfitabilityA+
- Weakest
- GrowthF
All factor grades
- ProfitabilityA+
- Financial StrengthA+
- ForecastA
- MomentumA-
- ValuationB-
- GrowthF
- Piotroski3/9
Contact
COYA stock: frequently asked questions
What is COYA's ST Score?
Coya Therapeutics, Inc. (COYA) has an ST Score of 64.5 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is COYA a buy, hold, or sell?
Analysts rate COYA a Buy, with a price target of $12.00 (+131.7% vs the current price). Our ST Score grades it B (64.5/100). The ST Score is a data-driven signal, not a recommendation.
What are COYA's factor grades?
Valuation B-, Profitability A+, Financial Strength A+, Momentum A-, Growth F, Forecast A.
What is COYA's valuation grade?
Coya Therapeutics, Inc. (COYA) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is COYA's growth grade?
Coya Therapeutics, Inc. (COYA) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is COYA's profitability grade?
Coya Therapeutics, Inc. (COYA) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is COYA's financial strength grade?
Coya Therapeutics, Inc. (COYA) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for COYA?
The average analyst price target for Coya Therapeutics, Inc. (COYA) is $12.00 from 6 analysts, which is +131.7% versus the recent price of $5.18.
What is COYA's Piotroski score?
Coya Therapeutics, Inc. (COYA) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.